Michelle Jenks
Overview
Explore the profile of Michelle Jenks including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
171
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Retzler J, Davies H, Jenks M, Kiff C, Taylor M
Clinicoecon Outcomes Res
. 2019 May;
11:309-324.
PMID: 31118714
Cost-effectiveness analyses (CEA) of new technologies typically include "background" costs (eg, all "related" health care costs other than the specific technology under evaluation) as well as drug costs. In oncology,...
2.
Murphy D, Jenks M, McCool R, Wood H, Young V, Amlani B
Expert Rev Pharmacoecon Outcomes Res
. 2019 Apr;
19(6):701-709.
PMID: 30938201
: Colonoscopies are carried out for a range of reasons including for the detection of colon cancer and investigation of abdominal and bowel related symptoms. Inadequate preparation can increase the...
3.
Marshall C, Shore J, Arber M, Cikalo M, Oladapo T, Peel A, et al.
Appl Health Econ Health Policy
. 2019 Mar;
17(4):453-465.
PMID: 30820871
Mepilex Border Sacrum and Heel dressings are self-adherent, multilayer foam dressings designed for use on the heel and sacrum aiming to prevent pressure ulcers. The dressings are used in addition...
4.
Peel A, Jenks M, Choudhury M, Lovett R, Rejon-Parrilla J, Sims A, et al.
Appl Health Econ Health Policy
. 2019 Feb;
17(2):263-264.
PMID: 30746616
In Sect. 3.3.1, the second sentence of the second paragraph.
5.
Peel A, Jenks M, Choudhury M, Lovett R, Rejon-Parrilla J, Sims A, et al.
Appl Health Econ Health Policy
. 2018 Aug;
16(6):819-836.
PMID: 30073485
Objectives: This study aimed to review current use of experts within National Institute for Health and Care Excellence (NICE) guidance-making programmes, identify improvements in use of expert judgement, and to...
6.
The Memokath-051 Stent for the Treatment of Ureteric Obstruction: A NICE Medical Technology Guidance
Eaton Turner E, Jenks M, McCool R, Marshall C, Millar L, Wood H, et al.
Appl Health Econ Health Policy
. 2018 Apr;
16(4):445-464.
PMID: 29616460
Memokath-051 is a thermo-expandable, nickel-titanium alloy spiral stent used to treat ureteric obstruction resulting from malignant or benign strictures. The National Institute for Health and Care Excellence (NICE) selected Memokath-051...
7.
Eaton Turner E, Jenks M
Expert Rev Pharmacoecon Outcomes Res
. 2017 Dec;
18(3):331-337.
PMID: 29187008
Objective: To estimate the cost-effectiveness of Nasal High Flow (NHF) in the intensive care unit (ICU) compared with standard oxygen or non-invasive ventilation (NIV) from a UK NHS perspective. Methods:...
8.
Jenks M, Willits I, Eaton Turner E, Hewitt N, Arber M, Cole H, et al.
Appl Health Econ Health Policy
. 2017 Jul;
15(5):567-582.
PMID: 28669043
The XprESS multi-sinus dilation system (XprESS) is a minimally invasive alternative to functional endoscopic sinus surgery (FESS) used in the treatment of people with chronic or recurrent acute sinusitis refractory...
9.
Willits I, Cole H, Jones R, Carter K, Arber M, Jenks M, et al.
Appl Health Econ Health Policy
. 2017 Mar;
15(4):539.
PMID: 28290104
No abstract available.
10.
Willits I, Cole H, Jones R, Carter K, Arber M, Jenks M, et al.
Appl Health Econ Health Policy
. 2017 Jan;
15(4):455-468.
PMID: 28110486
The Spectra Optia automated apheresis system, indicated for red blood cell exchange in people with sickle cell disease, underwent evaluation by the National Institute for Health and Care Excellence, which...